Abstract:Zerumbone (1) was isolated from fresh rhizomes of Zingiber zerumbet Smith in yields of 0.3-0.4% by simple steam distillation and recrystallization. 1 accepted 2 equiv of hydrogen cyanide at the C6 and C9 double bonds of the cross-conjugated dienone system to give a mixture of diastereomers 3a-d. In the presence of potassium cyanide, the dominant isomer 3a was isomerized to a mixture of 3a-d. Under controlled conditions, 1 added one mole of methanol regio- and stereoselectively at the C6 double bond to give add… Show more
“…1,2 Zerumbone has been shown to possess antitumor, anti-inflammatory, antioxidant, antimicrobial, antinociceptive, hepatoprotective, and immunomodulatory activity. This compound also significantly suppresses tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation in Raji cells and free radical (superoxide anion) generation in cancer cell lines, and strongly inhibits platelet aggregation induced by arachidonic acid, collagen, and adenosine diphosphate.…”
Zerumbone, a natural dietary lipophilic compound with low water solubility (1.296 mg/L at 25°C) was used in this investigation. The zerumbone was loaded into nanostructured lipid carriers using a hot, high-pressure homogenization technique. The physicochemical properties of the zerumbone-loaded nanostructured lipid carriers (ZER-NLC) were determined. The ZER-NLC particles had an average size of 52.68 ± 0.1 nm and a polydispersity index of 0.29 ± 0.004 µm. Transmission electron microscopy showed that the particles were spherical in shape. The zeta potential of the ZER-NLC was −25.03 ± 1.24 mV, entrapment efficiency was 99.03%, and drug loading was 7.92%. In vitro drug release of zerumbone from ZER-NLC was 46.7%, and for a pure zerumbone dispersion was 90.5% over 48 hours, following a zero equation. Using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay in human T-cell acute lymphoblastic leukemia (Jurkat) cells, the half maximal inhibitory concentration (IC 50 ) of ZER-NLC was 5.64 ± 0.38 µg/mL, and for free zerumbone was 5.39 ± 0.43 µg/mL after 72 hours of treatment. This study strongly suggests that ZER-NLC have potential as a sustainedrelease drug carrier system for the treatment of leukemia.
“…1,2 Zerumbone has been shown to possess antitumor, anti-inflammatory, antioxidant, antimicrobial, antinociceptive, hepatoprotective, and immunomodulatory activity. This compound also significantly suppresses tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation in Raji cells and free radical (superoxide anion) generation in cancer cell lines, and strongly inhibits platelet aggregation induced by arachidonic acid, collagen, and adenosine diphosphate.…”
Zerumbone, a natural dietary lipophilic compound with low water solubility (1.296 mg/L at 25°C) was used in this investigation. The zerumbone was loaded into nanostructured lipid carriers using a hot, high-pressure homogenization technique. The physicochemical properties of the zerumbone-loaded nanostructured lipid carriers (ZER-NLC) were determined. The ZER-NLC particles had an average size of 52.68 ± 0.1 nm and a polydispersity index of 0.29 ± 0.004 µm. Transmission electron microscopy showed that the particles were spherical in shape. The zeta potential of the ZER-NLC was −25.03 ± 1.24 mV, entrapment efficiency was 99.03%, and drug loading was 7.92%. In vitro drug release of zerumbone from ZER-NLC was 46.7%, and for a pure zerumbone dispersion was 90.5% over 48 hours, following a zero equation. Using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay in human T-cell acute lymphoblastic leukemia (Jurkat) cells, the half maximal inhibitory concentration (IC 50 ) of ZER-NLC was 5.64 ± 0.38 µg/mL, and for free zerumbone was 5.39 ± 0.43 µg/mL after 72 hours of treatment. This study strongly suggests that ZER-NLC have potential as a sustainedrelease drug carrier system for the treatment of leukemia.
“…According to a recent report by Newman et al, as many as 65% (48 out of 74) of formally synthetic drugs in the antihypertensive medicine are plant based (Newman et al, 2003). Zerumbone (2,6,9,9-tetramethyl-[2E,6E, 10E]-cycloundeca-2,6,10-trien-1-one; Figure 1) was first isolated in 1956 from the essential oil of rhizomes of a wild ginger, Zingiber zerumbet Smith, which is widespread in Southeast Asia (Dev, 1956;Kitayama et al, 1999). Over the years, a wide variety of activities have been assigned to this compound (Ozaki et al, 1991;Murakami et al, 1999Murakami et al, , 2002Murakami et al, , 2003aMurakami et al, , 2004Tanaka et al, 2001;Kirana et al, 2003).…”
“…The flexible nature of the large ring made it impossible to determine the configuration of 3 by NMR, even though NOEs of almost the same value were observed between the methoxy protons and those at C3 and C2, and no NOE was seen between the C2 methyl protons and the methoxy protons at C3. 7) In an attempt to add a cyanide ion to the remaining conjugated double bond, treatment of 3 with KCN resulted quantitatively in a mixture of the four diastereomeric dinitriles (2a-d) in the same ratio as above. The smooth substitution of the cyano for the methoxy group represents a reversal of the addition of methanol, and again illustrates the strong propensity of cyanide for conjugate addition.…”
Section: Conjugate Additionmentioning
confidence: 97%
“…The smooth substitution of the cyano for the methoxy group represents a reversal of the addition of methanol, and again illustrates the strong propensity of cyanide for conjugate addition. 7) Common primary and secondary amines reacted with 1 and 6,7-epoxide (4), which was prepared from 1 and MCPBA, at or below room temperature to give conjugate-added products at C3, and sometimes at C3 and C10 of the substrates. 8) In a tightly sealed container, 1 was stirred with excess concentrated aqueous ammonia in acetonitrile at room temperature to yield monoamine 5.…”
Section: Conjugate Additionmentioning
confidence: 99%
“…We built the foundations for the industrial use of 1 by establishing novel methods, including conjugate addition, 7) transannular reaction, 7,8) ring cleavage, [8][9][10] ring expansion, 11) and asymmetric induction. [12][13][14][15][16][17] For example, since many useful polycyclic compounds exist in nature, the development of the transannular reaction and the construction of various transannular products are very important in organic and material chemistry.…”
Zerumbone is a cyclic seaquiterpene and, a potential resource for natural materials-related diversityoriented synthesis (NMRDOS). Zerumbone, the main component of the essential oil of a wild ginger, Zingiber zerumbet Smith, showed strong reactivity with good chemo-, regio-, and stereoselectivity. To build the foundations for the industrial use of zerumbone, we examined conjugate addition, transannular reactions, ring cleavage, ring expansion, and asymmetric induction. The biological activity of zerumbone derivatives was also studied.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.